Comparison

Nitroxoline-d4 European Partner

Item no. HY-B1159S-1mg
Manufacturer MedChem Express
Amount 1 mg
Quantity options 10 mg 1 ea 1 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0.999
Citations [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Abouelhassan Y, et al. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria. Int J Antimicrob Agents. 2017 Feb;49(2):247-251.
Smiles OC1=C2N=C([2H])C([2H])=C([2H])C2=C([N+]([O-])=O)C=C1[2H]
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 8-Hydroxy-5-nitroquinoline-D4,5-Nitro-8-quinolinol-D4
Shipping Condition Room temperature
Available
Manufacturer - Type
Isotope-Labeled Compounds
Manufacturer - Targets
Antibiotic; Autophagy; Bacterial
Shipping Temperature
Room temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
194.18
Product Description
Nitroxoline-d4 is the deuterium labeled Nitroxoline. Nitroxoline is an antibiotic that has proven to be very effective at combating biofilm infections. Nitroxoline functions by chelating Fe2+ and Zn2+ ions from the biofilm matrix[1][2].
Manufacturer - Research Area
Infection; Cancer
Solubility
10 mM in DMSO
Manufacturer - Pathway
Anti-infection; Autophagy
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close